Sculptor Capital’s MiMedx Group MDXG Stock Holding History

Sculptor Capital’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-137,500	Closed	-$850K	–	276
2018 Q3	$850K	Sell	137,500 -306,400	-69%	-$1.38M	﹤0.01%	191
2018 Q2	$2.84M	Buy	+443,900	New	+$3.16M	0.01%	140

Other funds holding MDXG

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

TIM

Thompson Investment Management Madison, Wisconsin $872M AUM 35.59% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

WMC

Westwood Management Corporation Chicago, Illinois $270M AUM 54.59% 1-Year Est. Return

PAM

Pegasus Asset Management Montebello, New York $313M AUM 24.74% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Sculptor Capital's MDXG Position: Q4 2018 in Review

Sculptor Capital sold out of MiMedx Group (MDXG) in Q4 2018, closing a stake of 137,500 shares — an estimated $850K sold.

Sculptor Capital first reported a position in MDXG in Q2 2018 and held it in 2 quarters. The position peaked at $2.84M in Q2 2018. 38 funds tracked by Wall St. Rank hold MDXG as of Q4 2018.

Sculptor Capital reported no remaining MiMedx Group position as of Q4 2018 after selling out during the quarter.
Sculptor Capital sold 137,500 MiMedx Group shares in Q4 2018, an estimated $850K.
Sculptor Capital first reported a position in MiMedx Group in Q2 2018 and held it in 2 quarters.
Sculptor Capital's MiMedx Group position peaked at $2.84M in Q2 2018.
38 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2018.

Based on Sculptor Capital's 13F filing for Q4 2018, filed 13 Feb 2019.